Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis (Q22255551)

8 February 2023

J. Pearce

Jennifer

Pearce

1 reference

8 February 2023

A. Bethell

Andrew

Bethell

1 reference

8 February 2023

L. Dankova

Liliya

Dankova

1 reference

8 February 2023

C. Barbui

Corrado

Barbui

1 reference

8 February 2023

W. A. Tol

Wietse A

Tol

1 reference

8 February 2023

M. van Ommeren

Mark

van Ommeren

1 reference

8 February 2023

J. de Jong

Joop

de Jong

1 reference

8 February 2023

S. Seedat

Soraya

Seedat

1 reference

8 February 2023

H. Chen

Hanhui

Chen

1 reference

8 February 2023

J. I. Bisson

Jonathan I

Bisson

1 reference

British Journal of Psychiatry

8 February 2023

language of work or name

English

0 references

publication date

1 February 2015

0 references

published in

0 references

volume

206

0 references

issue

0 references

page(s)

93-100

0 references

cites work

Treatment of posttraumatic stress disorder with amitriptyline and placebo

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Association of torture and other potentially traumatic events with mental health outcomes among populations exposed to mass conflict and displacement: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Association between unreported outcomes and effect size estimates in Cochrane meta-analyses

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Pharmacotherapy for social phobia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A guide to guidelines for the treatment of PTSD and related conditions.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Inositol treatment of post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A controlled trial of phenelzine in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Sertraline as a treatment for PTSD: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): A pilot study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Psychological treatments for chronic post-traumatic stress disorder: Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Meta-analysis of the efficacy of treatments for posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021

Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.BP.114.148551

7 January 2021